Pflug Koory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.12M | Sell |
9,755
-7
| -0.1% | -$1.55K | 0.97% | 25 |
|
|
2025
Q4 | $2.23M | Sell |
9,762
-95
| -1% | -$21.6K | 1.04% | 21 |
|
|
2025
Q3 | $2.28M | Sell |
9,857
-69
| -0.7% | -$14.1K | 1.08% | 19 |
|
|
2025
Q2 | $1.84M | Sell |
9,926
-65
| -0.7% | -$12.1K | 0.94% | 24 |
|
|
2025
Q1 | $2.09M | Sell |
9,991
-304
| -3% | -$59.1K | 1.17% | 17 |
|
|
2024
Q4 | $1.83M | Sell |
10,295
-46
| -0.4% | -$8.46K | 0.93% | 25 |
|
|
2024
Q3 | $2.04M | Buy |
+10,341
| New | +$1.93M | 1% | 20 |
|
|
2024
Q1 | $2.25M | Sell |
12,360
-798
| -6% | -$138K | 1.11% | 18 |
|
|
2023
Q4 | $2.04M | Hold |
13,158
| – | – | 1.08% | 18 |
|
|
2023
Q3 | $1.96M | Sell |
13,158
-130
| -1% | -$19.1K | 1.13% | 18 |
|
|
2023
Q2 | $1.79M | Sell |
13,288
-45
| -0.3% | -$6.6K | 0.91% | 29 |
|
|
2023
Q1 | $2.12M | Sell |
13,333
-159
| -1% | -$24.3K | 1.16% | 21 |
|
|
2022
Q4 | $2.18M | Sell |
13,492
-159
| -1% | -$24.4K | 1.21% | 20 |
|
|
2022
Q3 | $1.83M | Buy |
13,651
+10
| +0.1% | +$1.44K | 1.12% | 21 |
|
|
2022
Q2 | $2.09M | Sell |
13,641
-65
| -0.5% | -$9.93K | 1.21% | 18 |
|
|
2022
Q1 | $2.22M | Sell |
13,706
-200
| -1% | -$29.1K | 1.12% | 20 |
|
|
2021
Q4 | $1.88M | Buy |
13,906
+133
| +1% | +$15.7K | 0.95% | 26 |
|
|
2021
Q3 | $1.49M | Sell |
13,773
-520
| -4% | -$59.4K | 0.81% | 34 |
|
|
2021
Q2 | $1.61M | Buy |
14,293
+698
| +5% | +$78.6K | 0.84% | 32 |
|
|
2021
Q1 | $1.47M | Sell |
13,595
-671
| -5% | -$71.8K | 0.81% | 36 |
|
|
2020
Q4 | $1.53M | Buy |
14,266
+2,302
| +19% | +$221K | 0.91% | 27 |
|
|
2020
Q3 | $1.22M | Sell |
11,964
-417
| -3% | -$39.3K | 0.83% | 36 |
|
|
2020
Q2 | $1.22M | Sell |
12,381
-18
| -0.1% | -$1.58K | 0.9% | 32 |
|
|
2020
Q1 | $945K | Buy |
12,399
+110
| +0.9% | +$9.37K | 0.84% | 37 |
|
|
2019
Q4 | $1.09M | Sell |
12,289
-292
| -2% | -$24.2K | 0.77% | 39 |
|
|
2019
Q3 | $953K | Buy |
12,581
+100
| +0.8% | +$6.86K | 0.72% | 44 |
|
|
2019
Q2 | $908K | Hold |
12,481
| – | – | 0.7% | 46 |
|
|
2019
Q1 | $1.01M | Sell |
12,481
-50
| -0.4% | -$4.09K | 0.79% | 42 |
|
|
2018
Q4 | $1.16M | Buy |
12,531
+2,276
| +22% | +$200K | 0.99% | 30 |
|
|
2018
Q3 | $970K | Sell |
10,255
-1,879
| -15% | -$178K | 0.78% | 44 |
|
|
2018
Q2 | $1.12M | Buy |
12,134
+2,090
| +21% | +$204K | 0.89% | 41 |
|
|
2018
Q1 | $951K | Buy |
10,044
+399
| +4% | +$43.8K | 0.78% | 43 |
|
|
2017
Q4 | $933K | Sell |
9,645
-325
| -3% | -$30.6K | 0.74% | 45 |
|
|
2017
Q3 | $886K | Hold |
9,970
| – | – | 0.72% | 46 |
|
|
2017
Q2 | $723K | Hold |
9,970
| – | – | 0.61% | 53 |
|
|
2017
Q1 | $650K | Hold |
9,970
| – | – | 0.57% | 58 |
|
|
2016
Q4 | $624 | Buy |
+9,970
| New | +$609K | 0.54% | 57 |
|
Other funds holding ABBV
VCM
VPM
Pflug Koory's ABBV Position: Q1 2026 in Review
Pflug Koory reduced its AbbVie (ABBV) stake by 0.07% in Q1 2026, selling an estimated $1.55K and leaving 9,755 shares worth $2.12M. The position accounts for 0.97% of the portfolio, ranked #25.
Pflug Koory first reported a position in ABBV in Q4 2016 and has held it in 37 quarters since. The position peaked at $2.28M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Pflug Koory held 9,755 shares of AbbVie worth $2.12M as of Q1 2026.
- Pflug Koory sold 7 AbbVie shares in Q1 2026, an estimated $1.55K.
- AbbVie made up 0.97% of Pflug Koory's portfolio in Q1 2026, its #25 holding.
- Pflug Koory first reported a position in AbbVie in Q4 2016 and has held it in 37 quarters since.
- Pflug Koory's AbbVie position peaked at $2.28M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Pflug Koory's 13F filing for Q1 2026, filed 22 Apr 2026.